Versatility of OnabotulinumtoxinA in Aesthetic Medicine.
Dermatol Surg
; 50(9S): S12-S17, 2024 Sep 01.
Article
en En
| MEDLINE
| ID: mdl-39196828
ABSTRACT
BACKGROUND:
OnabotulinumtoxinA is an injectable product that was introduced into medicine in the 1970s and has been the subject of thousands of clinical and nonclinical publications.OBJECTIVE:
To review the data related to the versatility of onabotulinumtoxinA in medical aesthetics.METHODS:
PubMed was searched to identify literature evaluating the effects of onabotulinumtoxinA, with preference given to randomized, placebo-controlled trials and safety meta-analyses.RESULTS:
OnabotulinumtoxinA is effective and safe across multiple facial indications, racial and ethnic groups, age groups, genders, and facial line severities. Patient-reported outcomes have been prioritized in aesthetic clinical trials and indicate high patient satisfaction and appearance-related psychological outcomes. Integrated safety meta-analysis and immunogenicity analyses have documented acceptable adverse event rates and low immunogenicity of onabotulinumtoxinA.CONCLUSION:
OnabotulinumtoxinA is a versatile aesthetic product supported by a strong literature base and positive physician and patient-reported outcomes that reflect a meaningful impact on patient's quality of life.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Envejecimiento de la Piel
/
Técnicas Cosméticas
/
Satisfacción del Paciente
/
Toxinas Botulínicas Tipo A
Límite:
Humans
Idioma:
En
Revista:
Dermatol Surg
/
Dermatol. surg
/
Dermatologic surgery
Asunto de la revista:
DERMATOLOGIA
Año:
2024
Tipo del documento:
Article